Picture EBD Group Bio-Europe Spring 2024 Barcelona 650x100px
Organisation › Details

Novo Nordisk A/S

Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat diabetes and other serious chronic diseases such as obesity and rare blood and endocrine disorders. We do so by pioneering scientific breakthroughs, expanding access to our medicines, and working to prevent and ultimately cure disease. Novo Nordisk employs about 47,000 people in 80 countries and markets its products in around 170 countries. *


  Group Novo Group (Group)
Products Industry pharmaceutical
  Industry 2 antidiabetic
Region Region Bagsværd
  Country Denmark
  Street Novo Allé
  City 2880 Bagsværd
  Tel 45-4444-8888
    Address record changed: 2020-12-02
Basic data Employees H: 10,001 to 50,00 (2021-12-13)
  Currency DKK
  Annual sales 111,696,000,000 (sales, net, consolidated (2017) 2017-12-31)
  Profit 38,130,000 (2017-12-31)
  Cash 18,852,000,000 (2017-12-31)
    * Document for »About Section«: Novo Nordisk A/S. (12/13/21). "Press Release: Novo Nordisk Invests more than DKK 17 bn in Expansion of the Manufacturing Facilities in Kalundborg, Denmark".
Record changed: 2024-02-12


Picture [iito] [LSE] Business Portal 650x200px

More documents for Novo Group (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Picture EBD Group Bio-Europe Spring 2024 Barcelona 650x300px

» top